Adenylosuccinic acid
Adenylosuccinic acid (Adenylosuccinate; Aspartyl adenylate) is a purine ribonucleoside monophosphate and plays a role in nucleotide cycle metabolite. Adenylosuccinic acid can be converted into fumaric acid through adenylosuccinate lyase. Adenylosuccinic acid has the potential for the study of duchenne muscular dystrophy (DMD) [1].
Product Specifications
CAS Number
19046-78-7
Product Name Alternative
Adenylosuccinate; Aspartyl adenylate
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/adenylosuccinic-acid.html
Purity
95.0
Solubility
10 mM in DMSO
Smiles
O=C(C[C@H](NC1=C2N=CN(C2=NC=N1)[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(O)(O)=O)C(O)=O)O
Molecular Formula
C14H18N5O11P
Molecular Weight
463.29
Precautions
H302, H315, H319, H335
References & Citations
[1]Timpani CA, et al. Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.Sci Rep. 2020 Jan 24;10 (1) :1125.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Natural Products
Clinical Information
Phase 1
Isoform
Human Endogenous Metabolite
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD45RO (UCHL-1), CF640R conjugate, 0.1mg/mL
MART-1 / Melan-A (M2-7C10), CF594 conjugate, 0.1mg/mL
Fibronectin (TV-1), CF594 conjugate, 0.1mg/mL
Cytokeratin 8/18 (C-51), CF405S conjugate, 0.1mg/mL
Complement C4d (C4D204), CF488A conjugate, 0.1mg/mL
